Arkolith/Insider Trading/FHTX/Form 4

Bellon Steven F.

Chief Scientific OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Sep 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$190K
Net Open-Market Flow
-$190K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2024Sell(S)20K$9.50$190K102K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006767) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML